Paget's Disease of the Vulva
Paget's disease of the vulva is a rare skin condition that typically manifests as red, scaly patches on the vulva, often associated with itching or discomfort. It can sometimes be linked to underlying malignancies.
Extra-Mammary Paget's Disease: PAGETEX Device Study
We are studying the PAGETEX device to see if it helps control Extra-Mammary Paget's Disease of the vulva. The trial will also look at pain levels, quality of life, and patient satisfaction during treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a woman aged 18 years or older?
- Are you currently pregnant or breastfeeding?
- Do you have invasive Paget's disease?
- Have you been treated with topical corticosteroids on the affected area in the last 3 months?
- Do you have any immune disorders like HIV or have you had an organ transplant?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Luxera
Luxerm
Metvix
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Lille
Dermatologie
La Madeleine, France
Sponsor: Centre Hospitalier Universitaire De Lille
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.